Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization to the biopharmaceutical and medical device industries, has added Tricia A. Bland to its management team as the Executive Director, Strategic Projects.
Ms. Bland brings over 20 years of demonstrated success in the clinical research industry, leading and implementing global development strategies and successfully managing global teams. She will be based out of Pharm-Olam’s Research Triangle Park, North Carolina office. Ms. Bland will provide executive-level leadership to both staff and sponsors, strategic relationship management, and implementation of process improvement programs aimed at increasing efficiencies and improving data quality. Prior to coming to Pharm-Olam, Ms. Bland held management roles including Vice President of Corporate Development and Vice President of Proposals and Contracts at several CROs.
“We are thrilled to have Tricia join the Pharm-Olam team,” said Sanjiv Suri, Pharm-Olam’s Chief Executive Officer (USA). Suri added, “We continually look for ways to assist pharmaceutical, biotechnology, and device companies with innovative clinical trial solutions around the world. We know how important our team members are to study success and Tricia’s addition to our team will enable us to offer distinctive ideas to support our client’s unique needs.”